A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market, extending a slow debut complicated by coverage questions and doctor concerns.
The infused drug, hailed as a potential breakthrough treatment for a fatal disease, has encountered a health care system that “remains…
Слотмашины сегодня в множестве вариантов представлены в известных интернет-казино глобально. Вращать слоты в платном формате в онлайн-казино с компьютера , планшетов. Поскольку аппараты с...